Tectonic Therapeutic Inc.

NASDAQ: TECX · Real-Time Price · USD
23.51
-0.96 (-3.92%)
At close: Aug 15, 2025, 3:59 PM
23.04
-2.00%
After-hours: Aug 15, 2025, 06:13 PM EDT

Tectonic Therapeutic Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.63M 1.56M 1.57M 1.44M 1.39M 2M 2.54M 5.23M 5.2M 4.67M 4.15M 1.52M 1.56M 1.51M 1.4M 1.27M 1.21M 1.22M
Gross Profit
-1.63M -1.56M -1.57M -1.44M -1.39M -2M -2.54M -5.23M -5.2M -4.67M -4.15M -1.52M -1.56M -1.51M -1.4M -1.27M -1.21M -1.22M
Operating Income
-74.26M -63.35M -58.02M -53.4M -43.88M -48.18M -60.44M -76.32M -89.19M -101.24M -105.43M -108.14M -117.77M -121.38M -118.84M -118.94M -123.04M -120.52M
Interest Income
9.52M 6.45M 4.26M 2.66M 803K 709K 701K 655K 670K 446K 198K 111K 2K 11K 21K 34K 44K 97K
Pretax Income
-65M -58.67M -57.98M -53.48M -57.34M 22.81M 13.07M -4.09M -5.48M -101.01M -105.89M -109.08M -118.73M -122.06M -119.13M -119.03M -123.2M -120.64M
Net Income
-65.98M -58.67M -49.57M -45.06M -48.92M 31.22M 13.07M -4.09M -5.48M -101.01M -105.89M -109.08M -118.73M -122.06M -119.13M -119.03M -123.2M -120.64M
Selling & General & Admin
20.56M 19.76M 21.66M 19M 19.94M 19.59M 19.73M 24.67M 25.47M 30.38M 33.25M 35.09M 37.6M 37.53M 35.73M 35.24M 33.56M 32.42M
Research & Development
53.69M 43.58M 31.01M 29.05M 29.56M 33.34M 49.88M 57.77M 58.52M 66.19M 68.04M 71.52M 78.61M 82.33M 81.71M 82.43M 88.27M 86.89M
Other Expenses
1K 1K 5.35M 5.35M 5.35M 5.34M -8K -8K -8K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
74.26M 63.35M 58.02M 53.4M 54.85M 58.28M 69.61M 82.44M 84M 96.56M 101.28M 106.61M 116.21M 119.87M 117.44M 117.67M 121.83M 119.31M
Interest Expense
84K 95K 106K 118K 129K 141K 110K 110K 74K 319K 689K 900K 900K 615K 245K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 5M 5M 9.18M 11.3M 12.05M 17.1M 12.93M 10.8M 5.05M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
74.26M 63.35M 58.02M 53.4M 54.85M 59.16M 71.41M 87.3M 89.19M 101.24M 105.43M 108.14M 117.77M 121.38M 118.84M 118.94M 123.04M 120.52M
Income Tax Expense
976K n/a -377K -377K -377K -377K n/a n/a n/a n/a n/a n/a -0.00 -0.00 -0.00 -0.00 n/a n/a
Shares Outstanding (Basic)
18.68M 17.16M 14.79M 5.71M 2.92M 3.73M 3.72M 3.71M 3.68M 3.67M 3.65M 3.65M 3.64M 3.64M 3.64M 3.64M 3.55M 3.47M
Shares Outstanding (Diluted)
18.68M 17.16M 14.79M 5.71M 2.92M 3.73M 3.72M 3.71M 3.69M 3.67M 3.65M 3.65M 3.64M 3.64M 3.64M 3.64M 3.55M 3.47M
EPS (Basic)
-5.95 -9.22 -10.11 -11.63 -9.2 13.49 8.51 4.01 -1.61 -27.66 -29.05 -29.95 -32.62 -33.76 -33.33 -34.33 -37.47 -38.21
EPS (Diluted)
-5.95 -9.22 -10.11 -11.63 -9.2 13.43 8.45 3.95 -1.67 -27.66 -29.05 -29.95 -32.62 -33.76 -33.33 -34.33 -37.47 -38.21
EBITDA
-66.97M -57.02M -56.3M -51.92M -44.3M -42.18M -51.41M -53.97M -66.95M -84.11M -89.14M -106.66M -116.26M -119.94M -117.48M -117.76M -121.98M -119.42M
EBIT
-64.92M -58.57M -57.88M -53.36M -45.69M -43.46M -53.23M -55.65M -68.6M -85.95M -90.46M -108.18M -117.83M -121.44M -118.88M -119.03M -123.2M -120.64M
Depreciation & Amortization
1.63M 1.56M 1.57M 1.44M 1.39M 2M 2.54M 5.23M 5.2M 4.67M 4.15M 1.52M 1.56M 1.51M 1.4M 1.27M 1.21M 1.22M